Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
542.60
473.42
645.80
679.89
656.98
410.01
370.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
542.60
473.42
645.80
679.89
656.98
410.01
370.17
Raw Material Cost
371.42
394.89
512.64
556.40
517.54
356.34
326.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
57.06
43.85
42.32
41.11
34.55
28.18
24.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
27.90
29.68
17.56
12.62
8.30
6.45
8.02
Selling and Distribution Expenses
116.67
27.60
36.97
17.35
15.34
9.38
7.65
Other Expenses
-84.96
-73.53
-59.88
-53.73
-42.84
-34.63
-32.64
Total Expenditure (Excl Depreciation)
488.09
422.48
549.62
573.75
532.87
365.72
333.82
Operating Profit (PBDIT) excl Other Income
54.51
50.93
96.18
106.14
124.11
44.29
36.35
Other Income
19.40
0.07
-1.24
-3.66
2.31
-3.19
-4.52
Operating Profit (PBDIT)
101.83
34.30
112.13
119.93
143.24
52.88
43.22
Interest
27.90
29.68
17.56
12.62
8.30
6.45
8.02
Exceptional Items
0.00
6.32
0.82
0.02
0.00
1.75
0.38
Gross Profit (PBDT)
171.18
78.53
133.15
123.49
139.45
53.67
44.00
Depreciation
27.92
27.62
17.21
17.64
16.12
12.12
11.41
Profit Before Tax
46.01
-16.68
78.18
89.68
118.82
36.06
24.17
Tax
3.08
-2.35
14.65
18.30
35.71
10.82
7.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.93
-14.33
63.53
71.39
83.11
25.24
16.31
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
5.0
5.0
5.0
10.0
10.0
10.0
10.0
Reserves
466.16
278.36
367.69
328.49
258.41
177.93
129.11
Earnings per share (EPS)
13.12
-30.36
15.59
25.87
30.11
9.14
5.91
Diluted Earnings per share
13.12
-30.36
15.59
25.87
30.11
9.14
5.91
Operating Profit Margin (Excl OI)
10.05%
1.4%
14.89%
15.58%
19.0%
10.72%
9.81%
Gross Profit Margin
13.62%
2.31%
14.77%
15.79%
20.54%
11.75%
9.61%
PAT Margin
7.91%
-3.03%
9.84%
10.5%
12.65%
6.16%
4.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 399.58% vs -122.56% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 140.81% vs -69.81% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Bajaj Healthcare With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
542.60
469.48
73.12
15.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
542.60
469.48
73.12
15.57%
Raw Material Cost
371.42
129.95
241.47
185.82%
Purchase of Finished goods
0
59.66
-59.66
-100.00%
(Increase) / Decrease In Stocks
0
-31.16
31.16
100.00%
Employee Cost
57.06
65.10
-8.04
-12.35%
Power Cost
0
0.00
0.00
Manufacturing Expenses
27.90
-0.01
27.91
279,100.00%
Selling and Distribution Expenses
116.67
0.00
116.67
Other Expenses
-84.96
136.14
-221.10
-162.41%
Total Expenditure (Excl Depreciation)
488.09
359.68
128.41
35.70%
Operating Profit (PBDIT) excl Other Income
54.51
109.80
-55.29
-50.36%
Other Income
19.40
11.82
7.58
64.13%
Operating Profit (PBDIT)
101.83
121.62
-19.79
-16.27%
Interest
27.90
14.19
13.71
96.62%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
171.18
107.43
63.75
59.34%
Depreciation
27.92
24.22
3.70
15.28%
Profit Before Tax
46.01
83.21
-37.20
-44.71%
Tax
3.08
6.81
-3.73
-54.77%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
42.93
76.40
-33.47
-43.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
42.93
76.40
-33.47
-43.81%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.46
-0.46
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.93
76.86
-33.93
-44.15%
Equity Capital
0
14.58
-14.58
-100.00%
Face Value
5.00
5.00
0.00
Reserves
466.16
348.09
118.07
33.92%
Earnings per share (EPS)
13.12
26.36
-13.24
-50.23%
Diluted Earnings per share
13.12
26.35
-13.23
-50.21%
Operating Profit Margin (Excl OI)
10.05%
23.39%
0.00
-13.34%
Gross Profit Margin
13.62%
22.88%
0.00
-9.26%
PAT Margin
7.91%
16.27%
0.00
-8.36%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 542.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 42.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 399.58% vs -122.56% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 140.81% vs -69.81% in Mar 2024
Annual - Interest
Interest 27.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.00% vs 69.02% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.05%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






